SK bioscience wins patent lawsuit against Pfizer over pneumococcal vaccine in Korea: Gyeonggi-do, Republic of Korea Friday, May 23, 2025, 10:00 Hrs [IST] SK bioscience, a global i ...

The growing demand for Foley catheters is driven by several important factors. Firstly, the rising global aging population is contributing to a highe ...

An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K.

The FDA’s independent advisors found Pfizer’s data lacked the precision needed to establish the efficacy of Talzenna in ...

Leukemia Therapeutics Treatment Market Advancements in leukemia treatments propel global market growth amid rising cancer incidence and R&D ...

Tempus AI, Inc.'s unique data assets and AI-driven oncology solutions make it a promising buy. Click to read more on why the ...

The U.S. Food and Drug Administration's advisory panel is set to vote on Thursday to recommend whether COVID-19 vaccines for ...

At least six organizations that claim to champion patient rights have deep financial and operational ties to Big Pharma and ...

Discover how AI labs are reshaping R&D by integrating machine learning, robotics, and smart data systems to accelerate ...